ArticleInternal medicine (Tokyo, Japan)2023
Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers.
Patrick SchöffskiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.